Company: BIVIW
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001520138-25-000198
Chunk: 16

Company: BIOVIE INC.
Filing Date: 2025-07-03
Form: S-1
Chunk 16
---
 full) based on an assumed public offering price of $10.30 per share (which       
 is the last reported sale price of our Common Stock on Nasdaq on June 26, 2025) and assumes no sale of Pre-funded Units, which, if sold,      
 would reduce the number of shares of Common Stock that we are offering on a one-for-one basis.                                                |
| Over-allotment Option:                              |     | We have granted the underwriters a 45 day option from the closing of                                                                          
 this offering, exercisable one or more times in whole or in part, to purchase up to an additional shares of Common Stock and/or up to         
 an additional Pre-funded Warrants and/or up to an additional Warrants or any combination thereof (15% of the total number of shares of        
 Common Stock, Pre-funded Warrants and Warrants to be offered by us in the offering) solely to cover over-allotments, if any.                  |
|                                                     |     | The over-allotment option purchase price to be paid per additional                                                                            
 share of Common Stock or Pre-funded Warrant by the underwriters shall be equal to the public offering price of one Unit or one Pre-funded     
 Unit, respectively, less $0.01 allocated to the Warrants and less the underwriting discount, and the purchase price to be paid per additional 
 Warrant shall be equal to $0.01, less the underwriting discount.                                                                              |
| Representative’s Warrants:                          |     | We have agreed to issue the Representative or its designees at the                                                                            
 closing of this offering a warrant to purchase the number of shares of Common Stock equal to 5.0% of the aggregate number of Units and        
 Pre-Funded Units sold in this offering. Each Representative’s Warrant will have an exercise price of $12.875 per share (representing          
 125% of the assumed public offering price of $10.30 per Unit, the last reported sale price of our Common Stock as reported on Nasdaq on       
 June 26, 2025), is immediately exercisable and will expire on the four- and one-half year anniversary of the date that is 180 days from       
 the commencement of sales of the securities issued in this offering. The Representative’s Warrants will provide for registration              
 rights (including a one-time demand registration right and unlimited piggyback rights) and customary anti-dilution provisions.                |

<div align='center'>7</div>

| Use of proceeds: |